<DOC>
	<DOCNO>NCT01027013</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy rebamipide 2 % suspension treatment patient dry-eye .</brief_summary>
	<brief_title>Safety Efficacy Study Rebamipide 2 % Ophthalmic Suspension Patients With Dry Eye</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Keratoconjunctivitis</mesh_term>
	<mesh_term>Rebamipide</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Age 18 year old Diagnosis dry eye define protocol Ongoing ocular disease may interfere study parameter . Inability stop use topical ophthalmic medication throughout duration study Inability stop use contact lenses duration study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>